Skip to main content

Laboratory Studies in Breast Implant Patients: ANA Positivity, Gammaglobulin Levels, and Other Autoantibodies

  • Conference paper
Immunology of Silicones

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 210))

Abstract

SILICONE induced connective tissue disease has been anecdotally but heavily documented over the past 20 years soon beginning after the introduction of the substance for prosthetic use [1–16].Other syndromes reported include synovitis, adenopathy, splenomegaly, systemic sclerosis, granuloma formation, and possible carcinogenesis.

Dr. Lewy of President of Breast Implant Research Inc of Houston Texas, and has both been deposed and testified in trial on breast implant related matters.

Dr. Ezrailson developed the Silicone Antibody Reactivity Assay (SARA™)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brown, JB, Fryer MP, David A. (1960).Study and use of synthetic materials such as silicone and teflon as subcutaneous protheses. Plastic and Reconstruct Surg. 26:264–27.

    Article  Google Scholar 

  2. Endo LP, Edwards NL, Longley S, Cormann LC, Panush RS. (1987).Silicone and rheumatic diseases. Semin Arthritis Rheum 17:112–118.

    Article  PubMed  CAS  Google Scholar 

  3. Fock KM, Feng PH, Tey B.(1984). Autoimmune disease developing after augmentation mammoplasty: report of 3 cases. J Rheumatol 11:98–100.

    PubMed  CAS  Google Scholar 

  4. Goldblum RM, Pelley RP, O’Donnell AA, Pyron D, Heggers JP (1992). Antibodies to silicone elastomers and reactions to ventribuloperitoneal shunts. Lancet; 340:510–513.

    Article  PubMed  CAS  Google Scholar 

  5. Heggers JP, Kossovsky N, Parson RW, Robson MC, Pelley RC, Talmage RJ.(1983). Biocompatibility of silicone implants. Ann Plastic Surg 11:38–45

    Article  CAS  Google Scholar 

  6. Kaiser W, Biesenback, Stuby U, Grafinger P, Zazgornik J (1990). Human adjuvant disease: remission of silicone-induced autoimmune disease after explanation of breast augmentation. Ann Rheum Dis 49:937–938.

    Article  PubMed  CAS  Google Scholar 

  7. Kossovsky N, Heggers JP, Robson MC. (1987).Experimental demonstration of the immunogenicity of silicone-protein complexes. J Biomed Mater Res 21:1125–33.

    Article  PubMed  CAS  Google Scholar 

  8. Okano V, Nishikai M, Sato A. (1984).Scleroderma, primary biliary cirrhosis and Sjogren’s syndrome after cosmetic breast augmentation with silicone injection: a case report of possible human adjuvant disease. Ann Rheum Dis 43:520–1.

    Article  PubMed  CAS  Google Scholar 

  9. Peimer CA, Medige J, Eckert BS, Wright JR, Howard CS (1986). Reactive synovitis after silicone arthroplasty. H Hand Surg IIA:624–38.

    Google Scholar 

  10. Sergott TJ, Limoli JP, Baldwin CM Jr, Laub DR.(1986). Human adjuvant disease, possible autoimmune disease after silicone implantation: a review of the literature, case studies, and speculation for the future. Plast Reconstr Surg 78:104–14

    Article  PubMed  CAS  Google Scholar 

  11. Silverstein MJ, Handel N, Gamagami P, Gierson ED, Furmanski M, Collins AR, Epstein M, Cohlan BF.(1992). Breast cancer diagnosis and prognosis in women following augmentation with silicone gel-filled prostheses. Eur J Cancer 1992; 28-635–640

    Article  PubMed  CAS  Google Scholar 

  12. Spiera H. (1988).Scleroderma after silicone augmentation mammoplasty. JAMA 260:236–8.

    Article  PubMed  CAS  Google Scholar 

  13. van Nunen SA, Gatenby PA, Basten A.(1983). Post-mammoplasty connective tissue disease. Arthritis Rheum 25:294–7.

    Google Scholar 

  14. Varga J, Jimenez SA. (1990).Augmentation mammoplasty and scleroderma. Is there an association? Arch Dermatol 126:1220–1221

    Article  PubMed  CAS  Google Scholar 

  15. Varga J, Schumacher HR, Jimenez SA. (1989).Systemic sclerosis after augmentation mammoplasty with silicone implants. Ann Intern Med 111:377–83.

    PubMed  CAS  Google Scholar 

  16. Yoshida K.(1973). Post mammoplasty disorder as an adjuvant disease of man. Shikoku Acta Med 29:318–32.

    Google Scholar 

  17. Sontheimer RD, McCauliffe DP,et al. (1992) Antinuclear Antibodies: Clinical Correlations and Biological Significance. Adv Dermat.7:3–52

    CAS  Google Scholar 

  18. Lipscomb MF, Cope LD, Stephens GL, et al.(1984) Comparison of substrates for the Detection of Antinuclear Antibodies in Normals and In Patients with Connective Tissue Disease and Other Diseases. Diagn Immunol 2:181–187.

    PubMed  CAS  Google Scholar 

  19. Anderson P.(1977). Correlation of amooth muscle and nuclear antibodies in normal subjects. Clin Exp Med 27:74–77.

    Google Scholar 

  20. Borak J, Vasey F, Lauter S et al.(1979). Immunofluorescence Assay for Antinuclear Factor: A Non-specific Test in Hospitalized Patients. Can Med J 121:1372–1374.

    CAS  Google Scholar 

  21. Shu S, Nidengard RJ, Hale WL et al (1975).Incidence and titers of Antinuclear Antismooth muscle and other autoantibodies in blood donors. J Lab Clin Med 86,259–265.

    PubMed  CAS  Google Scholar 

  22. Carsons S.( 1988).Newer laboratory parameters for the diagnosis of rheumatic disease. Am J Med 85(4A): 34–8

    Google Scholar 

  23. Shiel WC, Jason M.(1989) The Diagnostic Association of Patients with Antinuclear Antibodies Referred to a Community Rheumatologist. J Rheumatol. 91:249–255.

    Google Scholar 

  24. Smeenk RJ, van den Brink HG, Brinkman K, Termaat RM, Berden JH, Swaak AJ.(1991) Anti-dsDNA: choice of assay in relation to clinical value. Rheumatol Int 11(3): 101–7.

    Article  PubMed  CAS  Google Scholar 

  25. Tan EM.(1989).Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 93–151

    Google Scholar 

  26. De Vlam, K, De Keyser F, Verbruggen M. Et al.(1993). Detection and Identification of Antinuclear Antibodies in the Serum of Normal Blood Donors. Cliinical and Experimental Rheumatology 11:393–397.

    Google Scholar 

  27. Guilbert B, Dighiero G, Avrameas S. (1982). Naturally Occurring Antibodies Against Nine Common Antigens in Human Sera. J Immunol 128:2279–2287.

    Google Scholar 

  28. Segal R, Globerson A, Singer H et al.(1992) The Influence of Aging on the Induction and Manifestations of Experimental Systemic Lupus Erythematosus. J Clin Immunol. 12:5.341-346.

    Article  Google Scholar 

  29. Spiera H, Kerr LD.(1993).Scleroderma following silicone implantation: a cumulative experience of 11 cases. J Rheumatol 20(6): 958–61.

    PubMed  CAS  Google Scholar 

  30. Sahn EE, Garen PD, Silver RM, Maize JC.(1990).Scleroderma following augmentation mammoplasty. Report of a case and review of the literature [see comments] Arch Dermatol 126(9): 1198–202.

    Article  PubMed  CAS  Google Scholar 

  31. Gutierrez FJ, Espinoza LR.(1990).Progressive systemic sclerosis complicated by severe hypertension: reversal after silicone implant removal. Am J Med 89(3): 390–2.

    Article  PubMed  CAS  Google Scholar 

  32. Press Rl, Peebles CL, Kumagai Y, Ochs RL, Tan EM.(1992).Antinuclear autoantibodies in women with silicone breast implants. Lancet 340(8831): 1304–7.

    Article  PubMed  CAS  Google Scholar 

  33. Bridges AJ.(1994) Autoantibodies in patients with silicone implants. Semin Arthritis Rheum 24(1 Sup54-60): 54–60.

    Google Scholar 

  34. Bridges AJ, Conley C, Wang G, Burns DE, Vasey FB.(1993).A clinical and immunologic evaluation of women with silicone breast implants and symptoms of rheumatic disease [see comments] Ann Intern Med 118(12): 29–36.

    Google Scholar 

  35. Claman H,. Robertson AD. (1994).Antinuclear Antibodies and Breast Implants. West J Med. 160:225–228.

    PubMed  CAS  Google Scholar 

  36. Coleman, EA, Lemon SJ, Rudick J et al.(1994).Rheumatic Disease Among 1167 Women Reporting Local Implant and Systemic Problems After Breast Implant Surgery. Journal of Women’s Health. 3(3): 165–177.

    Article  Google Scholar 

  37. Wolf LE, Lappe M, Peterson RD, Ezrailson EG.(1993).Human immune response to polydimethylsiloxane (silicone): screening studies in a breast Implant population. FASEB J 7(13): 1265–8.

    PubMed  CAS  Google Scholar 

  38. Teuber SS, Rowley MJ, Yoshida SH, Ansari AA, Gershwin ME.(1993).Anti-collagen autoantibodies are found in women with silicone breast implants. J Autoimmun 6(3): 367–77.

    Article  PubMed  CAS  Google Scholar 

  39. Schusterman MA, Kroll SS, Reece GP, Miller MJ, Ainslie N, Halabi S, Batch CM.(1993).Incidence of autoimmune disease in patients after breast reconstruction with silicone gel implants versus autogenous tissue: a preliminary report. Ann Plast Surg 31(1): 1–6.

    PubMed  CAS  Google Scholar 

  40. Gabriel S, O’Fallon WM, Kurland L et al. (1994).Risk of Connective Tissue Diseases and Other Disorders After Breast Implantation. Nejm 330(24): 1697–1702.

    Article  PubMed  CAS  Google Scholar 

  41. Chang YH.(1993). Adjuvanticity and arthritogenicity of silicone. Plast Reconstr Surg 92(3): 469–73.

    Google Scholar 

  42. Clayton D and Hills M. (1993). Statistical Methods in Epidemiology. New York, Oxford Press. 53–62.

    Google Scholar 

  43. Brestow NE, Day NE.(1980). Statistical Methods in Cancer Research.Vol 1-the analysis of case-control studies. IARC Scientific Publications No 32. Lyon, International Agency for Research on Cancer, 146–154.

    Google Scholar 

  44. Kossovsky N, Zeidler M, Chun G et al.(1993). Surface Dependent Antigens Identified by High Binding Avidity of Serum Antibodies in a Subpopulation of Patients with Breast Prostheses. J of Appl. Biomat 4:281–288.

    Article  Google Scholar 

  45. Garrido L, Pfeiderer B, Papisov M et al.(1993). In vivo degradation of silicones. Magn Res Med 29(6):839–843.

    Article  CAS  Google Scholar 

  46. Swaak AJ, Huysen V, Nossent JC, Smeenk RJ. (1990).Antinuclear antibody profiles in relation to specific disease manifestations of systemic lupus erythematosus. Clin Rheumatol 9(1 Sup82-94): 82–94.

    Article  PubMed  CAS  Google Scholar 

  47. Winfield JB, Jarjour WN. (1991).Stress Proteins, Autoimmunity and Autoimmune Disease. CurrTop Microbiol Immunol 167:161–189.

    Article  CAS  Google Scholar 

  48. Weiss NL, Phillips MR, Sadock VA et al.(1990). False positive seroreactivity to Borrelia burgdorferi in rheumatic disease: the value of immunoblot analysis. Clinical Research 38:277A.

    Google Scholar 

  49. Yoshida SH, Teuber SS, Gerrman JB et al. (1994). Immunotoxicity of Silicone: Implications of Oxidant Balance Towards Adjuvant Activity. Fd Chem Toxic. 32:1089–1100.

    Article  CAS  Google Scholar 

  50. Yoshida SH, German JB, Fletcher MP et al.(1994). The toxic oil syndrome: a perspective on immunotoxicological mechanisms. Regulatory Toxicology and Pharmacology 19:60–79.

    Article  PubMed  CAS  Google Scholar 

  51. Heggers JP. (1994). Immunogenic Potential of Silicones and Subsequent Clinical Implications. Problems in General Surgery. 11(2): June, 1994.

    Google Scholar 

  52. Lappe MA. (1993). Silicone-Reactive Disorder: A New Autoimmune Disease Caused by Immunostimulation and Superantigens. 1993. Medical Hypotheses 41:348–352.

    Article  PubMed  CAS  Google Scholar 

  53. Drake CG, Kotzin BL. (1992). Superantigens: biology, immunology and potential role in disease. J Clin Immunol 12:149–162.

    Article  PubMed  CAS  Google Scholar 

  54. Quinlan T, Spivack S, Mossman BT. (1994). Regulation of Antioxidant Enzymes in Lung after Oxidant Activity. Environmental Health Perspectives 102:79–87, 1994.

    PubMed  CAS  Google Scholar 

  55. Morse J, Spiera H. (1992). Autoimmune Diseases, Immunoglobulin isotypes, and lymphocyte subsets in 30 females with breast augmentation mammoplasty. J Rheum:S65:185.

    Google Scholar 

  56. Barun WF. (1992). HLA molecules in autoimmune diseases. Clin Biochem 25:187–191.

    Article  Google Scholar 

  57. Fox Rl, Holl Kang. (1992). Genetic and Environmental Factors in Systemic Sclerosis. Curr Opin in Rheum 4:875–861.

    Google Scholar 

  58. Pilbrant A and Strindberg B. (1975).Pharmacokinetics of 2,6-cis-Diphenylhexamethylcyclotetrasiloxane in Man. Acta Pharm et Tox 36:suppl 3, 139–145.

    CAS  Google Scholar 

  59. Smalley DL. Puckett DH. Osborne SH et al.(1994). Immunologic Stimulation of Lymphocytes in Silicone Gel Breast Implant Patients. Abstract 7th Annual Meeting of the Association of Medical Laboratory lmmunologists, Boston, Mass. July 14.

    Google Scholar 

  60. Ojo-Amaize E A, Conte V, Lin H et al.(1994). Silicone-Specific Blood Lymphocyte Response in Women with Silicone Breast Implants. Clin Diag. Lab Immunol: 1(6):698–695.

    Google Scholar 

  61. Potter M, Morrison S, Wiener F, et al.(1994). Induction of Plasmacytomas with Silicone Gel in Genetically Susceptible Strains of Mice. J Nat Canc Inst 86(14):1058–1065.

    Article  CAS  Google Scholar 

  62. Naim JO, Lanzafame RJ, van Oss CJ.(1993). Adjuvant effect of silicone-gel on antibody formation in rats. Immunol Invest 22(2): 151–61

    Article  PubMed  CAS  Google Scholar 

  63. Shoaib B, Patten BM and Calkins DS. (1994).Adjuvant Breast Disease.An Evaluation of 100 Symptomatic Women with Breast Implants or Silicone Fluid Injections. Keio J Med 43(2):79–87.

    Article  PubMed  CAS  Google Scholar 

  64. Lewy, R.I.(1994). Auto immune Markers and Imaging Abnormalities in Silicone Breast Implant Users. Clinical Research, 42(2), 275A.

    Google Scholar 

  65. Lewy, R.I.(1994). Autoimmune Disease and Collagen Dermal Implants. Annals of Internal Medicine, 120(6), 524–525.

    Google Scholar 

  66. Komaroff AL.(1988).Chronic fatigue syndromes: relationship to chronic viral infections. J Virol Methods 21(1-4): 3–10

    Google Scholar 

  67. Solomon GA.(1994). Clinical and Laboratory Profile of Symptomatic Women with Silicone Breast Implants. Sem Arth Rheum 24(1)Suppl 29–37.

    Google Scholar 

  68. Freundlich B, Aitman C, Sandorf N et al.(1994). A Profile of Symptomatic Patients with Silicone Breast Implants: A Sjogren’s-like Syndrome. Sem Arth Rheum 24(1) Suppl 44–53.

    Article  CAS  Google Scholar 

  69. Borenstein D et al.(1994). Siliconosis: A Spectrum of Illness. Sem Arth Rheum 24(1) Suppl 1–7.

    Article  CAS  Google Scholar 

  70. Vasey FB, Havice DL, Bocanegra TS et al. (1994).Clinical Findings in Symptomatic Women with Silicone Breast Implants. Sem Arth Rheum 24(1) Suppl 22–28.

    Article  CAS  Google Scholar 

  71. Lewy Rl.(1995) Antinuclear Antibodies, Lipid Disturbances and Central Nervous System Imaging Abnormalities in Silicone Breast Implant Users. Journal of Investigative Medicine 43:333A.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Lewy, R.I., Ezrailson, E. (1996). Laboratory Studies in Breast Implant Patients: ANA Positivity, Gammaglobulin Levels, and Other Autoantibodies. In: Potter, M., Rose, N.R. (eds) Immunology of Silicones. Current Topics in Microbiology and Immunology, vol 210. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85226-8_36

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85226-8_36

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-85228-2

  • Online ISBN: 978-3-642-85226-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics